发明名称 | Ophthalmic formulations of cetirizine and methods of use | ||
摘要 | The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye. | ||
申请公布号 | US8829005(B2) | 申请公布日期 | 2014.09.09 |
申请号 | US201313899321 | 申请日期 | 2013.05.21 |
申请人 | Aciex Therapeutics, Inc. | 发明人 | Abelson Mark Barry;Chapin Matthew J.;Gomes Paul;Minno George;Nice Jackie |
分类号 | A61K31/495 | 主分类号 | A61K31/495 |
代理机构 | Cooley LLP | 代理人 | Cooley LLP |
主权项 | 1. A method for alleviating a sign or symptom of allergic conjunctivitis by topically administering to an eye of a subject in need thereof an ophthalmic formulation comprising a single active ingredient consisting of 0.24% (w/v) cetirizine twice daily, wherein the ophthalmic formulation a) does not contain a cyclodextrin; b) comprises 1% Polyethylene Glycol 400, NF, 0.2% Dibasic Sodium Phosphate, Anhydrous, USP, 0.25% Hypromellose, USP, 0.1% Polysorbate 80, NF, 1.8% Glycerin, USP, 0.01% Benzalkonium Chloride, NF, and Purified Water, USP; and c) has a pH 6.8-7.2. | ||
地址 | Boston MA US |